CHIBE in the News

Health Affairs: Health Affairs Council On Health Care Spending And Value Announces Membership

By | In the News

“Earlier this year, Health Affairs announced the establishment of the Council on Health Care Spending and Value. The Council will provide a focal point for evidence-based discussion, analysis, and action regarding what we get for our health care spending in the U.S., whether it is worth it, and how we might collectively take a more deliberate approach toward maximizing our investment in health care. Today, Health Affairs is pleased to announce the names of the twenty experts who have agreed to serve on the Council, alongside co-chairs Dr. William Frist, former US Senate Majority Leader, and Dr. Margaret Hamburg, foreign secretary of the National Academy of Medicine.” Read…

Read More

Health Payer Intelligence: High-Deductible Plans Lead Diabetics to Forgo, Delay Treatment

By | In the News

Workers with diabetes who switched to high-deductible health plans requiring additional out-of-pocket expenses are more apt to put off necessary check-ups, a new Annals of Internal Medicine study finds. A growing proportion of Americans — including those with diabetes — have high-deductible health insurance plans in which they must pay up to about $1,000 to $7,000 out-of-pocket yearly if they use healthcare services, researchers note. The out-of-pocket costs of those who converted to higher-deductible plans jumped by an average of 43 percent to 53 percent compared to those who remained in low-deductible plans throughout the study. However, studies up to now haven’t clearly…

Read More

Medscape: Do High Out-of-Pocket Costs Delay Diabetes Patients From Care?

By | In the News

Mandated enrollment into a high-deductible insurance plan delays the time it takes patients with diabetes to seek care for cardiovascular (macrovascular) disease-related symptoms, tests, and procedures, compared with those who remain on a low-deductible insurance plan, an observational, longitudinal study suggests. “High-deductible plans, which require potential out-of-pocket spending of approximately $1000 to $7000 per person per year for most nonpreventive care, have become an increasingly common feature of US commercial health insurance,” Frank Wharam, MD, MPH, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, and colleagues observe in their article, published online November 19 in the Annals…

Read More

Knowledge @ Wharton: Why the Vaping Business Is Going Up in Smoke

By | In the News

If you’re craving JUUL mango pods, you may be out of luck. This week, the U.S. Food and Drug Administration (FDA) launched an attack on the rising underage use of tobacco products – which it considers to be an epidemic – and imposed sharp sales restrictions on flavored electronic cigarettes. The FDA also announced plans to ban menthol cigarettes and flavored cigars. In anticipation of this regulatory ruling, JUUL Labs, the San Francisco company that makes JUUL e-cigarettes, said on Tuesday that it would suspend sales of most of its flavored e-cigarette pods in retail stores and would stop its social media promotions. Read more at Knowledge…

Read More

Mercury News: FDA plans heavy crackdown on electronic cigarettes

By | In the News

As soon as next week, FDA Commissioner Scott Gottlieb is expected to announce a ban on the sale of flavored e-cigarettes – the majority of vaping products sold – in tens of thousands of convenience stores and gas stations across the country, according to senior agency officials. According to its officials, the agency will also impose such rules as age-verification requirements for online sales. Read more at Mercury News 

Read More

The Daily Pennsylvanian: Penn Med physicians call for greater access to fentanyl test strips to combat growing opioid crisis

By | In the News

Fentanyl is an addictive opioid which is increasingly being pushed out into the market, largely because of its relatively cheap cost compared to other drugs such as heroin. Fentanyl poses risks of severe respiratory depression and death, particularly among those without opioid tolerance, according to a Penn Medicine press release published on Nov. 1. Penn Medicine physicians are also calling for more rapid, coordinated responses to combat the growing opioid crisis in Philadelphia. Read more at The Daily Pennsylvanian 

Read More

PR News Wire: TrueMotion, Penn Medicine, and Progressive Insurance to investigate strategies to reduce distracted driving

By | In the News

“This distracted driving research will be game-changing for road safety and auto insurance,” said TrueMotion CEO Ted Gramer. “Nudges have been effective across many areas, including smoking, retirement savings, and organ donations. Nudges could be equally effective for distracted driving. We’re excited to work with Penn and Progressive on this research.” Read more at PR News Wire

Read More

EurekAlert: Penn and CHOP receive $1.84 million to study ways to curb cell phone use while driving

By | In the News

The objective of the grant is to translate findings from the field of behavioral economics to interventions that can be delivered through smartphones to “nudge” drivers to reduce distracted driving arising from cell phone use. Behavioral economics combines insights and findings from psychology and economics to explain, and try to correct, counter-productive or predictably irrational decision-making. Read more at EurekAlert

Read More